Liver steatosis in Chinese HIV-infected patients with hypertriglyceridemia: characteristics and independent risk factors

Background Since Highly Active Antiretroviral Therapy (HAART) medications were made available in 2002, multiple serious side effects have been observed. However, no study has yet systematically evaluated the prevalence of liver steatosis, a very serious but treatable side effect.